Follow the InnoCare Pharma Ltd. share price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are listed on HK HK, under the oversight of HKEX. Market capitalisation: €2.7bn. The latest transaction was filed on 15 July 2026 (Other). Among the most active insiders: Shi Yigong. All data is free.
30
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
2 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 1,268 of 26,550 companies
79.3
score / 100
Value
78
Quality
81
FCF yld0.5%
Earn yld24%
EV/EBITDA4.8x
ROE·
Gross mgn92%
Net mgn27%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
InnoCare Pharma Ltd. is a biopharmaceutical company focused on developing treatments for autoimmune diseases and cancers. It emphasizes innovation and research to enhance patient lives.